DCGI approves clinical trials of Favipiravir used in influenza in Japan, China for COVID-19 CISR Director General
0
|
|||
DCGI approves clinical trials of Favipiravir used in influenza in Japan, China for COVID-19 CISR ... Show more
DCGI approves clinical trials of Favipiravir used in influenza in Japan, China for COVID-19 CISR Director General Show less
Embed: Hide
Comments